HEADER TRANSPORT PROTEIN 24-FEB-23 8II4 TITLE CRYSTAL STRUCTURE OF V30M-TTR IN COMPLEX WITH 6-HYDROXY BBM COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSTHYRETIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ATTR,PREALBUMIN,TBPA; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TTR, PALB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS THYROXINE, AMYLOIDOSIS, INHIBITOR, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR T.YOKOYAMA REVDAT 1 28-JUN-23 8II4 0 JRNL AUTH M.MIZUGUCHI,T.YOKOYAMA,T.OKADA,Y.NAKAGAWA,K.FUJII, JRNL AUTH 2 Y.NABESHIMA,N.TOYOOKA JRNL TITL BENZIODARONE AND 6-HYDROXYBENZIODARONE ARE POTENT AND JRNL TITL 2 SELECTIVE INHIBITORS OF TRANSTHYRETIN AMYLOIDOGENESIS. JRNL REF BIOORG.MED.CHEM. V. 90 17370 2023 JRNL REFN ESSN 1464-3391 JRNL PMID 37311373 JRNL DOI 10.1016/J.BMC.2023.117370 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.12_2829: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.44 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 38738 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.199 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1937 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 30.4370 - 3.6112 0.99 2802 148 0.1764 0.1802 REMARK 3 2 3.6112 - 2.8670 1.00 2701 142 0.1803 0.1716 REMARK 3 3 2.8670 - 2.5048 1.00 2653 140 0.1900 0.2069 REMARK 3 4 2.5048 - 2.2759 1.00 2636 139 0.1810 0.2437 REMARK 3 5 2.2759 - 2.1128 1.00 2652 139 0.1718 0.1907 REMARK 3 6 2.1128 - 1.9882 1.00 2596 136 0.1770 0.2284 REMARK 3 7 1.9882 - 1.8887 1.00 2617 138 0.1722 0.1932 REMARK 3 8 1.8887 - 1.8065 1.00 2610 137 0.1805 0.2119 REMARK 3 9 1.8065 - 1.7369 1.00 2607 138 0.1895 0.2243 REMARK 3 10 1.7369 - 1.6770 1.00 2589 136 0.1947 0.2269 REMARK 3 11 1.6770 - 1.6246 1.00 2625 138 0.2075 0.2335 REMARK 3 12 1.6246 - 1.5781 1.00 2578 136 0.2147 0.2477 REMARK 3 13 1.5781 - 1.5366 1.00 2595 137 0.2344 0.3004 REMARK 3 14 1.5366 - 1.4991 0.98 2540 133 0.2412 0.2546 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.960 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 1921 REMARK 3 ANGLE : 1.058 2630 REMARK 3 CHIRALITY : 0.083 282 REMARK 3 PLANARITY : 0.007 327 REMARK 3 DIHEDRAL : 23.015 678 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8II4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-MAR-23. REMARK 100 THE DEPOSITION ID IS D_1300035761. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-OCT-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-17A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.915 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38780 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.499 REMARK 200 RESOLUTION RANGE LOW (A) : 38.620 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 27.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 400, CACL2, SODIUM ACETATE, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 21.63200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.82800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.63200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.82800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 CAT PKQ B 201 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -31 REMARK 465 ARG A -30 REMARK 465 GLY A -29 REMARK 465 SER A -28 REMARK 465 HIS A -27 REMARK 465 HIS A -26 REMARK 465 HIS A -25 REMARK 465 HIS A -24 REMARK 465 HIS A -23 REMARK 465 HIS A -22 REMARK 465 GLY A -21 REMARK 465 SER A -20 REMARK 465 MET A -19 REMARK 465 ALA A -18 REMARK 465 SER A -17 REMARK 465 HIS A -16 REMARK 465 ARG A -15 REMARK 465 LEU A -14 REMARK 465 LEU A -13 REMARK 465 LEU A -12 REMARK 465 LEU A -11 REMARK 465 CYS A -10 REMARK 465 LEU A -9 REMARK 465 ALA A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PHE A -4 REMARK 465 VAL A -3 REMARK 465 SER A -2 REMARK 465 GLU A -1 REMARK 465 ALA A 0 REMARK 465 GLY A 1 REMARK 465 PRO A 2 REMARK 465 THR A 3 REMARK 465 GLY A 4 REMARK 465 THR A 5 REMARK 465 GLY A 6 REMARK 465 GLU A 7 REMARK 465 SER A 8 REMARK 465 LYS A 9 REMARK 465 PRO A 125 REMARK 465 LYS A 126 REMARK 465 GLU A 127 REMARK 465 MET B -31 REMARK 465 ARG B -30 REMARK 465 GLY B -29 REMARK 465 SER B -28 REMARK 465 HIS B -27 REMARK 465 HIS B -26 REMARK 465 HIS B -25 REMARK 465 HIS B -24 REMARK 465 HIS B -23 REMARK 465 HIS B -22 REMARK 465 GLY B -21 REMARK 465 SER B -20 REMARK 465 MET B -19 REMARK 465 ALA B -18 REMARK 465 SER B -17 REMARK 465 HIS B -16 REMARK 465 ARG B -15 REMARK 465 LEU B -14 REMARK 465 LEU B -13 REMARK 465 LEU B -12 REMARK 465 LEU B -11 REMARK 465 CYS B -10 REMARK 465 LEU B -9 REMARK 465 ALA B -8 REMARK 465 GLY B -7 REMARK 465 LEU B -6 REMARK 465 VAL B -5 REMARK 465 PHE B -4 REMARK 465 VAL B -3 REMARK 465 SER B -2 REMARK 465 GLU B -1 REMARK 465 ALA B 0 REMARK 465 GLY B 1 REMARK 465 PRO B 2 REMARK 465 THR B 3 REMARK 465 GLY B 4 REMARK 465 THR B 5 REMARK 465 GLY B 6 REMARK 465 GLU B 7 REMARK 465 SER B 8 REMARK 465 LYS B 9 REMARK 465 PRO B 125 REMARK 465 LYS B 126 REMARK 465 GLU B 127 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG B 103 CD NE CZ NH1 NH2 DBREF 8II4 A -19 127 UNP P02766 TTHY_HUMAN 1 147 DBREF 8II4 B -19 127 UNP P02766 TTHY_HUMAN 1 147 SEQADV 8II4 MET A -31 UNP P02766 INITIATING METHIONINE SEQADV 8II4 ARG A -30 UNP P02766 EXPRESSION TAG SEQADV 8II4 GLY A -29 UNP P02766 EXPRESSION TAG SEQADV 8II4 SER A -28 UNP P02766 EXPRESSION TAG SEQADV 8II4 HIS A -27 UNP P02766 EXPRESSION TAG SEQADV 8II4 HIS A -26 UNP P02766 EXPRESSION TAG SEQADV 8II4 HIS A -25 UNP P02766 EXPRESSION TAG SEQADV 8II4 HIS A -24 UNP P02766 EXPRESSION TAG SEQADV 8II4 HIS A -23 UNP P02766 EXPRESSION TAG SEQADV 8II4 HIS A -22 UNP P02766 EXPRESSION TAG SEQADV 8II4 GLY A -21 UNP P02766 EXPRESSION TAG SEQADV 8II4 SER A -20 UNP P02766 EXPRESSION TAG SEQADV 8II4 MET A 30 UNP P02766 VAL 50 ENGINEERED MUTATION SEQADV 8II4 MET B -31 UNP P02766 INITIATING METHIONINE SEQADV 8II4 ARG B -30 UNP P02766 EXPRESSION TAG SEQADV 8II4 GLY B -29 UNP P02766 EXPRESSION TAG SEQADV 8II4 SER B -28 UNP P02766 EXPRESSION TAG SEQADV 8II4 HIS B -27 UNP P02766 EXPRESSION TAG SEQADV 8II4 HIS B -26 UNP P02766 EXPRESSION TAG SEQADV 8II4 HIS B -25 UNP P02766 EXPRESSION TAG SEQADV 8II4 HIS B -24 UNP P02766 EXPRESSION TAG SEQADV 8II4 HIS B -23 UNP P02766 EXPRESSION TAG SEQADV 8II4 HIS B -22 UNP P02766 EXPRESSION TAG SEQADV 8II4 GLY B -21 UNP P02766 EXPRESSION TAG SEQADV 8II4 SER B -20 UNP P02766 EXPRESSION TAG SEQADV 8II4 MET B 30 UNP P02766 VAL 50 ENGINEERED MUTATION SEQRES 1 A 159 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER MET SEQRES 2 A 159 ALA SER HIS ARG LEU LEU LEU LEU CYS LEU ALA GLY LEU SEQRES 3 A 159 VAL PHE VAL SER GLU ALA GLY PRO THR GLY THR GLY GLU SEQRES 4 A 159 SER LYS CYS PRO LEU MET VAL LYS VAL LEU ASP ALA VAL SEQRES 5 A 159 ARG GLY SER PRO ALA ILE ASN VAL ALA MET HIS VAL PHE SEQRES 6 A 159 ARG LYS ALA ALA ASP ASP THR TRP GLU PRO PHE ALA SER SEQRES 7 A 159 GLY LYS THR SER GLU SER GLY GLU LEU HIS GLY LEU THR SEQRES 8 A 159 THR GLU GLU GLU PHE VAL GLU GLY ILE TYR LYS VAL GLU SEQRES 9 A 159 ILE ASP THR LYS SER TYR TRP LYS ALA LEU GLY ILE SER SEQRES 10 A 159 PRO PHE HIS GLU HIS ALA GLU VAL VAL PHE THR ALA ASN SEQRES 11 A 159 ASP SER GLY PRO ARG ARG TYR THR ILE ALA ALA LEU LEU SEQRES 12 A 159 SER PRO TYR SER TYR SER THR THR ALA VAL VAL THR ASN SEQRES 13 A 159 PRO LYS GLU SEQRES 1 B 159 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER MET SEQRES 2 B 159 ALA SER HIS ARG LEU LEU LEU LEU CYS LEU ALA GLY LEU SEQRES 3 B 159 VAL PHE VAL SER GLU ALA GLY PRO THR GLY THR GLY GLU SEQRES 4 B 159 SER LYS CYS PRO LEU MET VAL LYS VAL LEU ASP ALA VAL SEQRES 5 B 159 ARG GLY SER PRO ALA ILE ASN VAL ALA MET HIS VAL PHE SEQRES 6 B 159 ARG LYS ALA ALA ASP ASP THR TRP GLU PRO PHE ALA SER SEQRES 7 B 159 GLY LYS THR SER GLU SER GLY GLU LEU HIS GLY LEU THR SEQRES 8 B 159 THR GLU GLU GLU PHE VAL GLU GLY ILE TYR LYS VAL GLU SEQRES 9 B 159 ILE ASP THR LYS SER TYR TRP LYS ALA LEU GLY ILE SER SEQRES 10 B 159 PRO PHE HIS GLU HIS ALA GLU VAL VAL PHE THR ALA ASN SEQRES 11 B 159 ASP SER GLY PRO ARG ARG TYR THR ILE ALA ALA LEU LEU SEQRES 12 B 159 SER PRO TYR SER TYR SER THR THR ALA VAL VAL THR ASN SEQRES 13 B 159 PRO LYS GLU HET PKQ A 201 46 HET PKQ B 201 46 HETNAM PKQ [3,5-BIS(BROMANYL)-4-OXIDANYL-PHENYL]-(2-ETHYL-6- HETNAM 2 PKQ OXIDANYL-1-BENZOFURAN-3-YL)METHANONE FORMUL 3 PKQ 2(C17 H12 BR2 O4) FORMUL 5 HOH *167(H2 O) HELIX 1 AA1 ASP A 74 LEU A 82 1 9 HELIX 2 AA2 ASP B 74 LEU B 82 1 9 SHEET 1 AA1 8 SER A 23 PRO A 24 0 SHEET 2 AA1 8 LEU A 12 ASP A 18 -1 N ASP A 18 O SER A 23 SHEET 3 AA1 8 ARG A 104 SER A 112 1 O LEU A 111 N LEU A 17 SHEET 4 AA1 8 SER A 115 THR A 123 -1 O SER A 115 N SER A 112 SHEET 5 AA1 8 SER B 115 THR B 123 -1 O THR B 118 N TYR A 116 SHEET 6 AA1 8 ARG B 104 SER B 112 -1 N SER B 112 O SER B 115 SHEET 7 AA1 8 LEU B 12 ASP B 18 1 N LEU B 17 O LEU B 111 SHEET 8 AA1 8 SER B 23 PRO B 24 -1 O SER B 23 N ASP B 18 SHEET 1 AA2 8 GLU A 54 LEU A 55 0 SHEET 2 AA2 8 LEU A 12 ASP A 18 -1 N VAL A 14 O LEU A 55 SHEET 3 AA2 8 ARG A 104 SER A 112 1 O LEU A 111 N LEU A 17 SHEET 4 AA2 8 SER A 115 THR A 123 -1 O SER A 115 N SER A 112 SHEET 5 AA2 8 SER B 115 THR B 123 -1 O THR B 118 N TYR A 116 SHEET 6 AA2 8 ARG B 104 SER B 112 -1 N SER B 112 O SER B 115 SHEET 7 AA2 8 LEU B 12 ASP B 18 1 N LEU B 17 O LEU B 111 SHEET 8 AA2 8 GLU B 54 LEU B 55 -1 O LEU B 55 N VAL B 14 SHEET 1 AA3 8 TRP A 41 LYS A 48 0 SHEET 2 AA3 8 ALA A 29 LYS A 35 -1 N VAL A 32 O ALA A 45 SHEET 3 AA3 8 GLY A 67 ILE A 73 -1 O GLU A 72 N HIS A 31 SHEET 4 AA3 8 HIS A 88 ALA A 97 -1 O ALA A 91 N ILE A 73 SHEET 5 AA3 8 HIS B 88 ALA B 97 -1 O GLU B 89 N VAL A 94 SHEET 6 AA3 8 GLY B 67 ILE B 73 -1 N ILE B 73 O ALA B 91 SHEET 7 AA3 8 ALA B 29 LYS B 35 -1 N HIS B 31 O GLU B 72 SHEET 8 AA3 8 TRP B 41 LYS B 48 -1 O ALA B 45 N VAL B 32 CRYST1 43.264 85.656 63.886 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023114 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011675 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015653 0.00000